GGrantIndex
← Leaderboards

Julian Stelzer

Case Western Reserve University

$9,895,616
Attributed
$13,678,234
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY201325
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,678,234 · 7

By mechanism

R01$13,200,009 · 6
S10$478,225 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Heart

Research focus

HeartCardiacMolecularDesignMyocardiumIn VivoMutationRelaxationAnimalsMyosin AtpaseHemodynamicsMyosin-Binding Protein CRegulationNovel TherapeuticsActinsHeart DiseasesSarcomeresImpairmentFunctional DisorderGenerationsHeart FailureMuscle FunctionEffective TherapyOrgan

Grant awards (24)

Molecular Basis for cMyBP-C HCM variants$730,764
R01 · FY2025 · HL · contact PI
Biological basis of cardiac thick filament regulation$715,378
R01 · FY2025 · HL
Computer modeling of myosin binding protein C and its effects on cardiac contraction$681,335
R01 · FY2025 · HL · contact PI
Biological Basis of Genetic cMyBP-C Cardiomyopathies$658,863
R01 · FY2025 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$711,835
R01 · FY2024 · HL · contact PI
Biological Basis of Genetic cMyBP-C Cardiomyopathies$692,971
R01 · FY2024 · HL · contact PI
Novel downstream effectors of protein kinase G in hypertensive disease$609,772
R01 · FY2024 · HL · contact PI
Novel downstream effectors of protein kinase G in hypertensive disease$622,215
R01 · FY2023 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$576,780
R01 · FY2023 · HL · contact PI
Novel downstream effectors of protein kinase G in hypertensive disease$622,215
R01 · FY2022 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$570,805
R01 · FY2022 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$551,684
R01 · FY2022 · HL · contact PI
Novel downstream effectors of protein kinase G in hypertensive disease$622,215
R01 · FY2021 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$571,221
R01 · FY2021 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$551,684
R01 · FY2021 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$598,429
R01 · FY2020 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$551,216
R01 · FY2020 · HL · contact PI
Computer modeling of myosin binding protein C and its effects on cardiac contraction$594,809
R01 · FY2019 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$396,250
R01 · FY2017 · HL · contact PI
High resolution ultrasound for small animal imaging$478,225
S10 · FY2016 · OD · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$396,250
R01 · FY2016 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$390,306
R01 · FY2015 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$388,325
R01 · FY2014 · HL · contact PI
Functional consequences of FHC mutations in cardiac MyBPC$394,687
R01 · FY2013 · HL · contact PI